Present and future role of FDG-PET/CT imaging in the management of breast cancer

被引:34
作者
Kitajima, Kazuhiro [1 ,2 ]
Miyoshi, Yasuo [3 ]
机构
[1] Hyogo Coll Med, Dept Nucl Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, PET Ctr, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[3] Hyogo Coll Med, Dept Breast & Endocrine Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
基金
日本学术振兴会;
关键词
Fluorodeoxyglucose (FDG); Positron emission tomography/computed tomography (PET/CT); Breast cancer; Staging; Restaging; POSITRON-EMISSION-TOMOGRAPHY; POWERFUL PROGNOSTIC STRATIFICATION; COMPLETE PATHOLOGICAL RESPONSE; STANDARDIZED UPTAKE VALUE; SENTINEL NODE BIOPSY; WHOLE-BODY PET/CT; F-18-FDG PET/CT; NEOADJUVANT CHEMOTHERAPY; EARLY PREDICTION; BONE METASTASES;
D O I
10.1007/s11604-015-0516-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful tool for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the diagnosis, initial staging, restaging, early treatment response assessment, evaluation of metastatic disease response, and prognostication of breast cancer as well as various malignant tumors. We herein review the current place and role of FDG-PET/CT in the management of breast cancer, focusing on its usefulness and limitations in the imaging of these patients.
引用
收藏
页码:167 / 180
页数:14
相关论文
共 101 条
[1]   The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer [J].
Ahn, Jhii-Hyun ;
Son, Eun Ju ;
Kim, Jeong-Ah ;
Youk, Ji Hyun ;
Kim, Eun-Kyung ;
Kwak, Jin Young ;
Ryu, Young Hoon ;
Jeong, Joon .
ACTA RADIOLOGICA, 2010, 51 (08) :859-865
[2]   18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer [J].
Alberini, Jean-Louis ;
Lerebours, Florence ;
Wartski, Myriam ;
Fourme, Emmanuelle ;
Le Stanc, Elise ;
Gontier, E. ;
Madar, O. ;
Cherel, P. ;
Pecking, A. P. .
CANCER, 2009, 115 (21) :5038-5047
[3]   Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review [J].
Annunziata, Salvatore ;
Caldarella, Carmelo ;
Treglia, Giorgio .
WORLD JOURNAL OF RADIOLOGY, 2014, 6 (03) :48-55
[4]   Twenty-five years of follow-up in patients with operable breast carcinoma - Correlation between clinicopathologic factors and the risk of death in each 5-year period [J].
Arriagada, R ;
Le, MG ;
Dunant, A ;
Tubiana, M ;
Contesso, G .
CANCER, 2006, 106 (04) :743-750
[5]   The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques [J].
Aukema, T. S. ;
Rutgers, E. J. Th. ;
Vogel, W. V. ;
Teertstra, H. J. ;
Oldenburg, H. S. ;
Peeters, M. T. F. D. Vrancken ;
Wesseling, J. ;
Russell, N. S. ;
Olmos, R. A. Valdes .
EJSO, 2010, 36 (04) :387-392
[6]   Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer [J].
Aukema, Tjeerd S. ;
Straver, Marieke E. ;
Peeters, Marie-Jeanne T. F. D. Vrancken ;
Russell, Nicola S. ;
Gilhuijs, Kenneth G. A. ;
Vogel, Wouter V. ;
Rutgers, Emiel J. T. ;
Olmos, Renato A. Valdes .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) :3205-3210
[7]   Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations [J].
Avril, N ;
Rosé, CA ;
Schelling, M ;
Dose, J ;
Kuhn, W ;
Bense, S ;
Weber, W ;
Ziegler, S ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3495-3502
[8]   Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast [J].
Berg, Wendie A. ;
Madsen, Kathleen S. ;
Schilling, Kathy ;
Tartar, Marie ;
Pisano, Etta D. ;
Larsen, Linda Hovanessian ;
Narayanan, Deepa ;
Ozonoff, Al ;
Miller, Joel P. ;
Kalinyak, Judith E. .
RADIOLOGY, 2011, 258 (01) :59-72
[9]   [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy [J].
Berriolo-Riedinger, Alina ;
Touzery, Claude ;
Riedinger, Jean-Marc ;
Toubeau, Michel ;
Coudert, Bruno ;
Arnould, Laurent ;
Boichot, Christophe ;
Cochet, Alexandre ;
Fumoleau, Pierre ;
Brunotte, Francois .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (12) :1915-1924
[10]   Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis [J].
Bertagna, Francesco ;
Treglia, Giorgio ;
Orlando, Emanuela ;
Dognini, Lodovica ;
Giovanella, Luca ;
Sadeghi, Ramin ;
Giubbini, Raffaele .
JAPANESE JOURNAL OF RADIOLOGY, 2014, 32 (02) :59-68